Presents an overview of the injustice of loss and damage, discusses the complexities and knowledge gaps, and proposes next steps for an interdisciplinary research agenda.
Organoids are three-dimensional, functional structures that mimic in vivo organs. They offer new opportunities for the modeling of cancer and infectious and rare hereditary diseases. Furthermore, the advent of organoid biobanks opens new avenues for drug screening in a personalized fashion and holds much promise for personalized regenerative medicine. Thus, there is a need for reproducible, large-scale organoid generation with minimal variability, making manual approaches impracticable. Here, we review the current use of automation in organoid culture and analysis, using cerebral and retinal organoids as illustrations of current applications. An increased demand for automated organoid platforms is anticipated.
This book chapter advances SDG3 Good Health and Wellbeing and SDG10 Reducing Inequalities by focusing on the minimization of impairments and the disabling consequences of disease.
Elsevier,
Long-Acting Drug Delivery Systems
Pharmaceutical, Clinical, and Regulatory Aspects
Woodhead Publishing Series in Biomaterials
2022, Pages 163-202
This content aligns with Goal 3: Good Health and Wellbeing by highlighting the significant role of long-acting drug delivery systems in improving the management of gynecological cancers, AIDS, and other pathological conditions, along with updates for the systems that are already present on the market such as contraceptive methods and AIDS prophylaxis.
Elsevier,
Bone Sarcomas and Bone Metastases - From Bench to Bedside (Third Edition), Bone Sarcomas and Bone Metastases - from Bench to Bedside, 2022, Pages 17-23
Examines the economic impact of bone metastasis for patients with cancer. Supports SDG 3.4.1 to 3.4 , reduce by one thirdmortality rate attributed to cardiovascular disease, cancer, diabetes or chronic respiratory diseases.
Elsevier,
Boissonneault, M. and Rios, P., 2021. Changes in healthy and unhealthy working-life expectancy over the period 2002–17: a population-based study in people aged 51–65 years in 14 OECD countries. The Lancet Healthy Longevity, 2(10), pp.e629-e638.
This study supports SDGs 3 and 8 by estimating the healthy and unhealthy working-life expectancy in 14 countries between 2002 and 2017. The study used cross-sectional data from surveys on ageing. Across all countries, increases in the number of years working were accompanied by an increased number of unhealthy working years, most frequently due to hypertension or arthritis.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by exploring the impact of COVID-19 on employment, childcare, food security, and mental health.
This review compared the effects between bioplastics compared to conventional plastics. It found that bioplastics caused less harm and will help policymakers to determine whether bioplastics is beneficial to the environment.
An Editorial on the importance of mitigating climate change, in the context of SDGs 3 and 16, calling for urgent governmental action to achieve climate justice.
A Personal View in support of SDGs 1, 2, and 13, describing how use of quantitative data can support targeted interventions for nutrition resiliency and suggesting actions that can help to prevent acute malnutrition in the context of worsening climate and conflict conditions.
